InvestorsHub Logo
Followers 31
Posts 1587
Boards Moderated 0
Alias Born 01/27/2011

Re: ~ Blue ~ post# 5323

Friday, 08/25/2017 10:12:13 AM

Friday, August 25, 2017 10:12:13 AM

Post# of 7747
CytRx Corporation (NASDAQ: CYTR) announced that on August 22, 2017, it received a letter from NASDAQ indicating its failure to regain compliance with the minimum $1.00 bid price requirement by August 21, 2017, which will serve as a basis for delisting its common stock from NASDAQ. The company recently announced that it has scheduled a Shareholders’ Meeting currently scheduled for October 17, 2017, where it will seek approval for a reverse split. The company plans to request a stay of the delisting action until at least following the meeting. Approval for a reverse split will allow the company to continue being listed on NASDAQ. However, rejection will result in a delist to the OTC Market.